CCB continues to face challenging outlook


KUALA LUMPUR: Affin Hwang Capital research maintained its sell rating on Cycle & Carriage Bintang Bhd with an unchanged target price of RM1.18.

In a note, it said CCB's profitability is expected to remain under pressure due to intense competition other other brands and Mercedes dealers, higher capex and opex and aggressive marketing.

However, it added that the relatively higher margins from new model launches in 2019-20E should help to cushion some of the margin erosion.

Affin Hwang expects CCB to report a lower 2019 revenue as compared to 2018, when there was a tax holiday.

"In 5M19, the total sales of Mercedes Benz (Merc) in Malaysia (by CCB and other dealers) slipped by 3.5% yoy to 5.0k units. 

"Meanwhile, Merc’s main competitor, BMW, has increased its 5M19 sales by 6.5% yoy to 4.6k units (including sales of the Mini)," it said.

CCB maintained its market share of 36% amid intense competition among Mercedes authorised dealers. 

The group will contiue to refurbish and expand its customer touchpoints nationwide to support Mercedez-Benz Malaysia's network development and to align with Daimler AG's corporate identity, said Affin Hwang.




Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Industrial projects look increasingly attractive
Protecting trade is protecting yourself
Fed dampens hopes for rate cut
F&N to use cost management measures
Naza makes entry into green economy
CapBay aims to provide financing to more SMEs
New initiative for infrastructure needs in Perak
Ocean Fresh seeks ACE Market listing
Rents for luxury homes in Singapore jump in 1Q amid wider slump
WTK to buy 15% stake in Durafarm

Others Also Read